The Long View of Diagnostic Delay in Axial Spondyloarthritis At #ACR25, Abstract #1407 presented a cross-sectional analysis from the Brazilian Spondyloarthritis Registry (RBE), offering a unique perspective on how diagnostic patterns have evolved over six decades. https://t.co/7ttYXJtfpc

#ACR25 – Day 2 Report Here are 3 abstracts that caught my eye on Day 2 at #ACR25. Notably these have takeaway messages that should support your current practices. https://t.co/xKPAgeWudD https://t.co/Fb16l6A252

Cellular Biomarkers of Rheumatoid Arthritis Dr. Jeffrey Sparks reports on four abstracts at #ACR25. https://t.co/ZO259DXIcW https://t.co/HOpgiXfYvM

PsA: Impact of Sex Dr. Arthur Kavanaugh highlights the importance of sex on disease characteristics and response to therapy in psoriatic arthritis, reporting from #ACR25. https://t.co/QtU4iATexR https://t.co/uCJsxYpFTc

Nerandomilast for ILD Dr. Mike Putman reports on abstract 1662 (Efficacy and Safety of Nerandomilast in Patients with Autoimmune Disease-Related Progressive Pulmonary Fibrosis: Subgroup Analysis of the FIBRONEER-ILD trial). #ACR25 https://t.co/J0e4SbVgFE https://t.co/dlOM700yVQ

#ACR25 Best Abstracts - Day 2 After a full day at the Chicago Convention center the RheumNow faculty have posted some of their favorite reports included these that they labeled as being the "best' of day 2. https://t.co/gyIWQXVJ50 https://t.co/vjlK41hzFD

Are we putting the CAR-T before the horse? CAR T-cells have been a revolutionary development in rheumatology. We have seen a population of patients with severe refractory autoimmune conditions almost overnight presented with the prospect of not just improvement, but of a cure. https://t.co/niPU5cAojP

Marketscan claims study of 62,813 IMID women w/ 70,529 pregnancies & 69,412 births, 4,485 (7.1%) were exposed to at least one TNFi during pregnancy & 3,559 postpartum. TNFi use NOT assoc w/ SIE risk during Preg (HR 1.39; 0.95-2.05) or postpartum (HR 1.22; https://t.co/NsxOLpT0ds

💬 #ACR25 Topic Panels — LIVE! Nov. 5 join RheumNow at 7 PM ET for a deep dives into the hottest topics in rheumatology: 👉 SpA Join Us Live on: X • Facebook • YouTube • LinkedIn • https://t.co/V10S4oVFsv Top experts. Real clinical insight. Don't miss these discussions https://t.co/ARrEpN2ybC

GLP-1 and SGLT-2: Treatments Too Good to Ignore? Dr. Peter Nash reviews several studies presented on GLP-1s at #ACR25. He recommends for review abstracts: 0841, 0849, 1027, 2685, 0165, 0233 and 2658. https://t.co/OclO05bpku https://t.co/kASID9jnAP

B Cell Depletion: Check the Lymph Node Dr. Akhil Sood reports on abstract 2695 (B-cell depletion and lymphoid follicle disruption upon different B-cell depleting agents) presented at #ACR25. https://t.co/BjgIC3Kng0 https://t.co/flfyLZYW8q

🌟 Wonderful news! One of the EMEUNET Top 10 Abstracts ACR 2025 has been accepted on Rheumatology! 🎊 Congratulations Erdem Bektas (@ebektasmd ) for this achievement! 👉You can read the manuscript in this link: https://t.co/teEscaBVG3 #EMEUNET https://t.co/BKRXTXiQ8U